Abstract
New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple Myeloma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v130.suppl_1.1783.1783
Copy DOIJournal: Blood | Publication Date: Jun 25, 2021 |
New Alternatives for the Evaluation of Minimal Residual Disease (MRD) Detection By Next Generation Sequencing in Multiple Myeloma
Join us for a 30 min session where you can share your feedback and ask us any queries you have